Oblique Therapeutics
SwedenEntry
2020
Hold
6yr
Status
Active
Who owns Oblique Therapeutics?
Oblique Therapeutics is a Swedish Biotech company, currently owned by Sunstone Life Science Ventures since 2020 and Almi Invest.
Hand-verified · updated 2026-08-18
Open JSON · CC-BYMost recent investor
Sunstone Life Science VenturesSunstone Life Science Ventures IV · 2015 · VC
2 ownership periods · full history below
Key facts
HQSweden
SectorBiotech
StatusActive
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2015 · present
Almi InvestActive
2015 · present(11yr) · Almi Invest (Regional funds) · 2009 · VC
More from Sunstone Life Science Ventures IV
Other portfolio companies in the same fund.
Switzerland
Finland
Denmark
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Oblique Therapeutics?
Oblique Therapeutics is currently owned by Sunstone Life Science Ventures and Almi Invest, through Sunstone Life Science Ventures IV, since 2020.
When did Sunstone Life Science Ventures and 1 other acquire Oblique Therapeutics?
Sunstone Life Science Ventures and 1 other acquired Oblique Therapeutics in 2020.
Who has owned Oblique Therapeutics over time?
Oblique Therapeutics has been through 2 private-equity ownership periods: Almi Invest · via Almi Invest (Regional funds) · since 2015; Sunstone Life Science Ventures · via Sunstone Life Science Ventures IV · since 2020.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue